Cobalt and GlaxoSmithKline Finally Reach Settlement

Michael Coyle
February 26, 2007

It was announced on 15 November 2006 that Cobalt Laboratories Inc. has reached a patent litigation settlement with GlaxoSmithKline Plc. regarding its Âsumatriptan succinate tabletsÂ, the generic version of GlaxoSmithKline’s Imitrex, which is sold to treat migraine pain.

Cobalt Pharmaceuticals Inc. announced in a statement that the company may distribute a genericÂ version in the U.S. by the first quarter of 2009 following the settlement which remains subject toÂ government review.

This was just one term that was agreed between lawyers, but the statement did not provideÂ additional details on the other terms of the settlement.

share this Article

Recent Articles

Nike v StockX, NFTs and Counterfeit products

American footwear and apparel company Nike has launched trademark infringement actions against the Detroit-based trainers and streetwear resale platform StockX, after allegedly using Nike’s Intellectual

Defamation claim filed by activist Jack Monroe over MP comments

Having been successful for a similar claim in the past, food writer and activist Jack Monroe has filed a libel claim in the UK after

Wagatha Christie WAGS at war Trial starts today!

Reaching the peak of proceedings, the defamation trial between Colleen Rooney and Rebecca Vardy starts in the High Court this week. This matter has been

Need Legal Advice? Book a Free Consultation

Lawdit ® Solicitors is the trading name of Lawdit Solicitors Ltd. Regulated by the Solicitors Regulation Authority of England and Wales.

Southampton Office

Isle of Wight Office

Quick Links

Lawdit ® Solicitors © 2022. All Rights Reserved.

Website by Nosy.Marketing